The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
Open accessAbstract
Objectives The purpose of this study was to estimate the effect of long-term exposure to lower plasma low-density lipoprotein cholesterol (LDL-C) on the risk of coronary heart disease (CHD).Background LDL-C is causally related to the risk of CHD. However, the association between long-term exposure to lower LDL-C beginning early in life and the risk of CHD has not been reliably quantified.Methods We conducted a series of meta-analyses to estimate the effect of long-term exposure to lower LDL-C on the risk of CHD mediated by 9 polymorphisms in 6 different genes. We then combined these Mendelian randomization studies in a meta-analysis to obtain a more precise estimate of the effect of long-term exposure to lower LDL-C and compared it with the clinical benefit associated with the same magnitude of LDL-C reduction during treatment with a statin.Results All 9 polymorphisms were associated with a highly consistent reduction in the risk of CHD per unit lower LDL-C, with no evidence of heterogeneity of effect (I(2) = 0.0%). In a meta-analysis combining nonoverlapping data from 312,321 participants, naturally random allocation to long-term exposure to lower LDL-C was associated with a 54.5% (95% confidence interval: 48.8% to 59.5%) reduction in the risk of CHD for each mmol/l (38.7 mg/dl) lower LDL-C. This represents a 3-fold greater reduction in the risk of CHD per unit lower LDL-C than that observed during treatment with a statin started later in life (p = 8.43 × 10(-19)).Conclusions Prolonged exposure to lower LDL-C beginning early in life is associated with a substantially greater reduction in the risk of CHD than the current practice of lowering LDL-C beginning later in life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous epidemiological studies, Mendelian randomization studies, and RCTs have consistently demonstrated a log-linear relationship between the absolute changes in plasma LDL-C and the risk of ASCVD [34,45-50].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, genetic variants reflect the effect of lifelong changes in ApoB-containing lipoproteins on the risk of cardiovascular disease, which appear to be cumulative over time.5,34”
From Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“Additionally, increasing evidence also suggests that the duration of exposure to low LDL-C levels may be as important as the magnitude of LDL-C lowering [11][12][13][14][15][16].”
In the citing paper
“A large meta-analysis by Ference et al. has demonstrated that prolonged exposure to lower LDL-C levels beginning at a young age is associated with a substantially greater reduction in the risk of CVD than the current practice of lowering LDL-C levels later in life [13].”
In the citing paper
“It was found that lifelong exposure to low LDL-C levels as a result of these gene polymorphisms was associated with three-fold greater reduction in the risk of CVD per unit lower LDL-C level than that observed during treatment with a statin started later in life.”
In the citing paper
“The long-term follow-up of large clinical trials of statins that were conducted in the 1990s, such as the West of Scotland Coronary Prevention Study (WOSCOPS) and the Heart Protection Study (HPS)628, 629) confirmed that early initiation of LDLC-lowering therapy regardless of the plasma LDL-C level was useful for the long-term prevention of cardiovascular events and all-cause mortality in high-risk”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [628]
In the citing paper
“No increases in new-incidence cancer or non-CVD deaths were observed, which reconfirms the safety of long-term LDL-C-lowering therapy using statins.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [628]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies (2011) · Nature · doi:10.1038/nature10405 · Cited by 2,033
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Cited by
Sorted by citations
Items 801–900 of 901
CO-MORBIDITIES AS DETERMINANTOF HEART FAILURE: A HOSPITAL BASED MATCHED CASE-CONTROL STUDY
Shafiq, M. S., Islam, F., Maryam, A., Ghafoor, J., & Akram, A. (2022) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v5i1.172
High-density lipoprotein cholesterol — friend or enemy?
Murzakhanova, A. F., OSLOPOV, V. N., Sergienko, K. S., Khazova, E. V., & OSLOPOVA, J. V. (2022) · Kazan medical journal · doi:10.17816/kmj2022-79
Epidemiology of Atherosclerotic Vascular Disease
Andersson, C., & O’Donnell, C. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_46-1
Dirjayanto, V. J. (2021) · JIMKI Jurnal Ilmiah Mahasiswa Kedokteran Indonesia · doi:10.53366/jimki.v9i2.409
Blood lipids and molecular pathways of atherogenesis
Stein, R., Ferrari, F., & Martins, V. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00021-3
Genetic Epidemiology of Atherosclerotic Vascular Disease
O’Donnell, C. J., & Fu, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_47-1
Epidemiology of Cardiovascular Disease in Children
Gidding, S. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-31420-4_13-1
Statine und neue Therapieoptionen zur Behandlung der LDL-Hypercholesterinämie
Katzmann, J. L., & Laufs, U. (2020) · Diabetes aktuell · doi:10.1055/a-1237-0720
Treating dyslipidemia: something more than giving statins
Masana, L. (2019) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2019.03.004
Redel‐Traub, G., Smilowitz, N. R., Xia, Y., & Berger, J. S. (2022) · Vascular Medicine · doi:10.1177/1358863x221098459
Mendys, P., Moskowitz, A., & Simpson, R. J. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.033
Hypertension and Hypercholesterolemia: Let’s Make Therapy Easy and Efficient
Sudano, I. (2022) · Praxis · doi:10.1024/1661-8157/a003894
Wen, X.-Q., Huang, K., Li, J., Wu, L.-X., & Gao, B. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221107232
Monu, M., & Gandhi, G. (2022) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-022-00090-5
Genetic Risk Stratification and the Primary Prevention of Coronary Artery Disease
Fair, J., Acuna, E., & Roberts, R. (2022) · Medical Research Archives · doi:10.18103/mra.v10i8.3039
Alieva, A. S., Usova, E., & Reutova, O. (2022) · European Atherosclerosis Journal · doi:10.56095/eaj.v1i2.14
Wang, I., Hou, S., Rahman, M. H. U., Li, X., Ritchie, D. A., & Spector, A. L. (2022) · Journal of Neurology and Epidemiology · doi:10.12974/2309-6179.2022.07.03
Márk, L. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.1.63
Catapano, A. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00013-3 · Cited by 1
Genetic Risk Stratification Will Enhance Primary Prevention of Coronary Artery Disease
Roberts, R., & Acuna, E. (2023) · Medical Research Archives · doi:10.18103/mra.v11i7.1.4063
Híd a szakadék felett : A lipidcsökkentő kezelés ajánlásai és a valósága
Reiber, I., & Mező, I. (2023) · Lege Artis Medicinae · doi:10.33616/lam.33.0364
Thompson‐Paul, A. M., Sekkarie, A., & Loustalot, F. V. (2023) · American Public Health Association eBooks · doi:10.2105/9780875533377ch14
Treatment of dyslipidemia in acute coronary syndrome
Yadav, S., & Sawhney, J. P. S. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.01.011 · Cited by 1
Additional file 1 of A phenome-wide association study of genetically mimicked statins
Li, S., & Schooling, C. M. (2021) · Figshare · doi:10.6084/m9.figshare.14880632
Tam, C. H. T., Lim, C. K. P., Luk, A. O. Y., Ng, A. C. W., Lee, H. M., Jiang, G., Lau, E. S. H., Fan, B., Wan, R., Kong, A. P. S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14068007
Impact of Rare and Common Genetic Variants on Lipoprotein Metabolism
Motazacker, M. M., Kastelein, J. J. P., & Kuivenhoven, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00006-2
Turner, F. R. T., & Stein, E. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00030-x
Detection and Stabilisation of Vulnerable Plaques in the Coronary Arteries
Бикбаева, Г. Р., Kovalskaya, A. N., Rodin, A., Pavlova, T. V., & Duplyakov, D. V. (2024) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2023.35
Gene-statin interaction study identifies 9 loci that moderate statin effectiveness in blood lipidsPreprint
Verhulst, B., Harris, J., Adams, A. M., Benstock, S. E., Tong, C. W.-C., Case, A. J., & Hettema, J. M. (2024) · Research Square · doi:10.21203/rs.3.rs-4720582/v1
Xu, L., Yu, W., Que, D., Yan, J., Zhang, X., Zhu, Y., Wang, Y.-X., Yang, Y., Song, X., & Yang, P. (2024) · Research Square · doi:10.21203/rs.3.rs-5242718/v1 · Cited by 1
Was ist gesichert in der Therapie der Fettstoffwechselstörungen?
Leitolf, H., & Hellweg, S. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01813-0
Saladini, F., Baggio, S., Marcato, F., Campisi, F. C., Verlato, R., Pasquetto, G., Bertaglia, E., Povolo, G., Buja, P., & Ferri, N. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247505
Borczyk, M., Machnik, N., Hajto, J., Krätschmer, I., Konowalska, P., Baszkiewicz, B., Korostyński, M., & Robinson, M. R. (2025) · medRxiv · doi:10.1101/2025.04.29.25326633
Bempedoic Acid in Patients with Dyslipidemia: A Systematic Review and Meta-Analysis
Samajdar, S. S., Sarkar, S., Chakraborty, S., Sarkar, D., Ghosh, S., Banerjee, S., Biswas, K., Pal, J., Chatterjee, N., Bandyopadhyay, S. K., et al. (2025) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_576_24
Ibarra, M. O. D. L. R., Pons, J. L. L., Reyes, H. R., Farjat-Ruiz, J. I., Gamba, M. A. A., Alcocer, A., Morales-Villegas, E., Corral, P., Ward, N. C., & Lugo‐Gavidia, L. M. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf425
Genetic evidence for causal effects of inflammatory protein factors on breast cancer
Liu, X., Xu, X., Ye, P., Jiang, Z., Tian, L., Yin, Y., & Li, F. (2025) · Discover Oncology · doi:10.1007/s12672-025-03370-w
Dhabuwala, A., Senapati, S. G., Lapsiwala, B. J., Wala, L., Madhavaram, N. J., Kolli, D., & Desai, R. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001006
Ziaie, N., Barary, M., Bakhshinasab, S., Hamzehpour, R., & Ebrahimpour, S. (2025) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.70019
Janeczek, M., Korbel, R., Janeczek, F., Alber, H., Küchenhoff, H., & Rinder, M. (2025) · Animals · doi:10.3390/ani15172493
Pupykina, V. V., & Zakharova, I. N. (2025) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2025.3.203414
Fontes, T., Lopes, S., Cebola, M., Carolino, E., Menezes, R., Rodrigues, L. M., & Ferreira‐Pêgo, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-09421-0
LDL-cholesterol lowering, the earlier the better: lessons from the real world
Miname, M. H., & Santos, R. D. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf131
Kiratipaisarl, W., Surawattanasakul, V., Sirikul, W., & Phinyo, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217617
Iqbal, J., Sathian, B., Ali, S. M., Shukaili, K. S. A., & Malik, A. P. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104463
Yin, M., Cui, F., Xu, X., Yang, Y., Chen, S., Sun, Y., Zhen, Y., Zhai, H., Wu, S., & Fang, H. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.09.009
Metwally, A. M., Elaraby, N. M., Ezzat, W. M., Dimitry, M. O., Elshaarawy, G. A., Ashaat, N. A., Reda, A., Bendary, A., Abbas, M. H., Mawardy, T. R. E., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02814-0
Chen, G., Liu, C., Xia, Y., Wang, P.-X., Zhao, Z., Li, A.-Y., Zhou, C.-Q., Xiang, C., Zhang, J.-L., Zeng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26750933
Li, C., Chen, Q., Zhang, M., Liu, Y., Chu, Y., Meng, F., Wang, J., Tang, J., Luo, J., Niu, X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13612425
Tam, C. H. T., Lim, C. K. P., Luk, A. O. Y., Ng, A. C. W., Lee, H.-M., Jiang, G., Lau, E. S. H., Fan, B., Wan, R., Kong, A. P.-S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14068004
Kim, Y. G., Jeong, J. H., Han, K.-D., Roh, S.-Y., Min, K., Lee, H. S., Choi, Y. Y., Shim, J., Choi, J.-I., & Kim, Y.-H. (2023) · Figshare · doi:10.6084/m9.figshare.22606822
Additional file 2 of A phenome-wide association study of genetically mimicked statins
Li, S., & Schooling, C. M. (2021) · Figshare · doi:10.6084/m9.figshare.14880635
Chen, G., Liu, C., Xia, Y., Wang, P.-X., Zhao, Z., Li, A.-Y., Zhou, C.-Q., Xiang, C., Zhang, J.-L., Zeng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26750936
Demirci, F., Emeç, M., Özcanhan, M. H., Doruk, Ö. G., & Akan, P. (2025) · The Anatolian Journal of General Medical Research · doi:10.4274/anatoljmed.2025.79663
Shi, Z., Mulford, A. J., Wei, J., Tran, H., Ashworth, A., Zheng, S., Helfand, B. T., Duggan, D. J., Dunnenberger, H. M., Hulick, P. J., et al. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200572
Gavina, C., Araújo, F., Luz, A. R., Jácome, C. I. O., Ruivo, J., & Teixeira, C. (2026) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2026.15.1.138
Бойцов, С. А., Владиславович, Е. М., Gurevich, V. S., Marchenkova, L. A., Sergienko, I. V., Tkacheva, O. N., Kotovskaya, Y. U. V., Mkhitaryan, E. A., Vasenina, E. E., Orlova, Y. A., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6678
Liuzzo, G., & Volpe, M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag011
Almeida, E. A., Mehndiratta, M., Kirubalenin, S. P., Madhu, S., & Kar, R. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1440
Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk
Miñambres, I., & Pérez, A. (2026) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2026.500894
Yılmaz, A., & Süygün, H. (2026) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.1854937
Cunha, A., Correia, J. P., Lobo, J. C., Elias, F. B., Leite, P. C., Brazão, C., Lucas, A., & Loyens, D. B. (2026) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2025.11.011
From residual risk to real risk: why implementation fails when we misunderstand the problem
Shapiro, M. D. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf665
Gavina, C., Seabra, D., Oliveira, S., Teixeira, C. A. C., Ruivo, J., Lourenço‐Silva, N., Luz, A. R., Jácome, C. I. O., & Araujo, F. P. (2026) · Global Heart · doi:10.5334/gh.1543
Clinical Assessment of Anti-Atherogenic Function of HighDensity Lipoprotein (HDL)
Ma, F. (2018) · theses.fr (ABES) · doi:10.70675/aec01babza8edz47a2zb4d4zc7c3be00b185
Injibar, M. M. D. (2021) · theses.fr (ABES) · doi:10.70675/dc8e6a7bz9cf4z4b17zaf41z02a43347a06b
Pacinella, G., Salvo, A., Maida, C. D., Daidone, M., Scaglione, S., Ciaccio, A. M., & Tuttolomondo, A. (2026) · Nutrients · doi:10.3390/nu18081273
Zhang, F., & Liao, Q. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1790509 · Cited by 1
Multi-omics evidence reveals a causal role of endoplasmic reticulum stress in cancer development
Guo, R., Qiu, X., Tao, T., Wang, Y., Zheng, S., Nie, S., Zhang, Q., & Gong, Y. (2026) · PeerJ · doi:10.7717/peerj.21164
Regular exercise modifies the effects of 12 LDL-C SNPs on cardiovascular disease risk: KoGES
Park, Y. C., Cho, A., Kim, Y. W., Kim, Y. W., Park, J. M., Han, K., Kim, B., Kim, K., Shin, J., Kwon, Y.-J., et al. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02963-w
Sánchez‐Quesada, J. L., & Pérez, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1813342
Low-density lipoprotein (LDL) in serum and measures of well-being
Koshino, A., & Hara, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-28842-5.00017-x
Dosage of lipoproteins for risk management according to guidelines
Bonnin, C., Fourgeaud, C., Mahé, G., Ezzaki, K., Gras, M., Himpens, F. X., Jacquet, R., Khider, L., Mirault, T., Poggi, J. N., et al. (2026) · Vascular Diseases · doi:10.1016/j.vasdi.2026.05.001
Nuotio, J., Laitinen, T. T., Magnussen, C. G., & Juonala, M. (2026) · Contemporary cardiology · doi:10.1007/978-3-032-14256-6_9
Parcero-Valdés, J. J., Magaña-Serrano, A., Arias‐Mendoza, A., Narváez-Oríani, C. A., Altamirano-Cardoso, E., Barrios, V., Díaz-Barreiro, L. A., López, A. A. P., & Gómez-Álvarez, E. (2026) · Cardiovascular and Metabolic Science · doi:10.35366/123178
Lipid Profile Abnormalities and Their Association with Cardiovascular Risk Factors in Adult Patients
Kader, M., Hasan, M. R., Ansary, E. A. F., & Rahman, A. (2026) · Islami Bank Medical College Journal · doi:10.70945/ibmcj.v021i01.022
Yan, Z., Pu, X., Cai, Y., Wu, Q., Zhang, X., Chang, X., Liu, J., Wang, Y., Liu, Z., & Liu, R. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07902-6
Ahn, J., Rhee, H., Chung, H. J., Hong, E., & Ryu, J. C. (2026) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2026.6.e21
Luo, J., Rasmussen, I. J., Thomassen, J. Q., & Frikke‐Schmidt, R. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120824 · Cited by 1
Mendelian randomisation in ophthalmology: An overview and practical guide for clinicians
Stuart, K. V., Warwick, A., Peng, C. L., Rajasundaram, S., & Khawaja, A. P. (2026) · European Journal of Ophthalmology · doi:10.1177/11206721261461915
Genedy, N., Haralambos, K., Yousef, Z., Cole, D., Datta, D., & Zouwail, S. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.06.030
Marco-Benedí, V., Bea, A. M., Ortega, E., Zamora, A., Gimeno, J. A., Guijarro, C., Cortés, B., Gonzalez, A., Vera, A. S. D., & Sánchez-Hernández, R. M. (2026) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2026.500958
Björnson, E., & Adiels, M. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01442-y
Obesity, lipids, inflammation, and healthy aging
Rikhi, R. R., & Shapiro, M. D. (2026) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2026.08.006
Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care
Carlson, A. M., Zayyad, Z. A., Driesenga, S., Boxley, P., Mishra, A., Uraizee, O., Ephrem, R., Zhang, R., Natsheh, Z., & Shroff, A. R. (2026) · Cardiology and Therapy · doi:10.1007/s40119-026-00473-5
Srivastava, R. A. K. (2026) · Cells · doi:10.3390/cells15171575
From particle count to residence time: a kinetic framework for atherogenic risk
Larronde, E. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1898635
Sabouret, P. F., Mafrica, D., Giamundo, D. M., Popiołek-Kalisz, J., Asher, E., Atar, D., & Andò, G. (2026) · Life · doi:10.3390/life16091470
Wang, S., Tang, Y., Sui, Y., Zhao, H., Khan, A., Yin, W., Chen, Q., Xu, T., Liu, Z., Zhang, Z., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00865-9 · Cited by 1
Mohamed, A. A., Rached, R., Kantsø, L. R., Honoré, E. T., Lauridsen, B. K., Fijolek, A., & Gislason, G. (2026) · Open Heart · doi:10.1136/openhrt-2026-004265
Serikawa, N., Yoshikawa, M., Arashi, H., Shibahashi, E., Otsuki, H., Kawada‐Watanabe, E., Ogawa, H., Yamaguchi, J., & Hagiwara, N. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134781
Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD
Roberts, R., & Roberts, M. (2026) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1851
From Metabolic Dysfunction to Vascular Remodeling
Ran, J., & Chen, Z. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001475
Cholesterol: Facts and Opinions by a Non-lipid Cardiologist
Roberts, R. (2026) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1826
Watt, J., Kurth, M. J., Rice, C., Green, J., Lamont, J. V., Laura, M., Dowey, L. R. C., Fitzgerald, P., & Ruddock, M. W. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1949855
Yu, H., Zhang, X., Yang, S., Fan, Z., Zhang, D., & Dan, W. A. N. G. (2026) · Lipids · doi:10.1002/lipd.70085
LDL-C vs Lp(a): What We Know, the “Zero-LDL” Hypothesis, and Where We Stand in the PCSK9 Era
Anamika, F., Dawar, P., Aggarwal, K., Dixit, S., Saravanan, G. K., & Nanjundappa, A. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001477
Ye, W., Zhang, H., Xiao, N., Qiaoqi, Y., Xue, Y., & Xue, J. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02090-4
Xie, X., Qian, S., Chang, D., Bhangale, T., McCarthy, M. I., Eraslan, G., & Fletez‐Brant, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.14.759213
Valle, C. D., Zuin, M., & Bilato, C. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70267
Metadata
- Authors
- Ference, B. A., Yoo, W., Alesh, I., Mahajan, N., Mirowska, K. K., Mewada, A., Kahn, J., Afonso, L., Williams, K. A., & Flack, J. M.
- Affiliations
- Wayne State University (US)
- University of Tennessee Health Science Center (US)
- Detroit Medical Center (US)
- Corresponding author
- Ference, Brian A.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 60
- Issue
- 25
- Pages
- 2631-2639
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W72392028
- Cited by
- 898
- References
- 44
- Citations by year
- 2026: 69 · 2025: 61 · 2024: 65 · 2023: 80 · 2022: 64 · 2021: 69 · 2020: 81 · 2019: 74 · 2018: 55 · 2017: 48 · 2016: 82 · 2015: 67 · 2014: 41 · 2013: 37 · 2012: 2
- FWCI
- 47.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novartis
- Medtronic
- NIH
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- LDL cholesterol, coronary heart disease risk, genetic polymorphism, Mendelian randomization, statin therapy, LDL cholesterol lowering, cardiovascular risk reduction
- MeSH terms
- Coronary Artery Disease, Follow-Up Studies, Genetic Markers, Humans, Cholesterol, LDL, Polymorphism, Genetic, Risk Factors, Time Factors, Global Health, Incidence, Risk Assessment, Genetic Predisposition to Disease, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
